Nano-Zirconium Dioxide Catalyzed Multicomponent Synthesis of Bioactive Pyranopyrazoles That Target Cyclin Dependent...

Area of Science:

• Medicinal Chemistry
• Organic Synthesis
• Cancer Biology

Background:

• Cyclin-dependent kinases (CDKs) are crucial drug targets in cancer therapy due to their role in cell cycle regulation.
• Inhibition of CDK enzymes is a validated strategy for treating various cancer types.

Purpose of the Study:

• To synthesize and identify novel pyranopyrazole derivatives as potential inhibitors of CDK enzymes.
• To investigate the catalytic role of nano-zirconium dioxide in the synthesis of these compounds.
• To evaluate the efficacy of the synthesized compounds against human breast cancer cells.

Main Methods:

• Multicomponent reaction catalyzed by nano-zirconium dioxide for pyranopyrazole synthesis.
• In-situ analysis of reaction intermediates using Gibbs free energy calculations.
• In vitro cell viability assays using MCF-7 human breast cancer cells.
• In vitro and in silico mode-of-action studies to identify the molecular target.

Main Results:

• Nano-zirconium dioxide effectively catalyzed the synthesis of pyranopyrazoles via multicomponent reaction.
• Compounds 5b and 5f demonstrated significant loss of viability in MCF-7 cells (IC50 values of 17.83 µM and 23.79 µM, respectively).
• Mode-of-action studies confirmed that these pyranopyrazoles target CDK1 in human breast cancer cells, with potent IC50 values for compounds 5b (960 nM) and 5f (7.16 µM).

Conclusions:

• Newly synthesized pyranopyrazoles are effective inhibitors of CDK1.
• These compounds show potential as lead structures for developing novel CDK1 inhibitors for human breast cancer treatment.
• The use of nano-zirconium dioxide offers an efficient synthetic route for these bioactive molecules.